Cabaletta Bio logo
Cabaletta Bio CABA
$ 1.87 -0.27%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Cabaletta Bio Balance Sheet 2011-2024 | CABA

Annual Balance Sheet Cabaletta Bio

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-188 M -76.5 M - -101 M -136 M -33 M -1 K - - - - - -

Long Term Debt

1.46 M 2.96 M - - - - - - - - - - -

Long Term Debt Current

3.56 M 2.18 M - - - - - - - - - - -

Total Non Current Liabilities

- - - - - 43.9 M - - - - - - -

Total Current Liabilities

16 M 9.49 M 8.38 M 5.18 M 3.15 M - - - - - - - -

Total Liabilities

17.5 M 12.4 M 8.38 M 5.18 M 3.15 M 44.9 M 250 K - - - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-233 M -166 M -113 M -66.3 M -33 M -12.5 M -250 K - - - - - -

Total Assets

254 M 117 M 126 M 115 M 141 M 34.2 M 1 K - - - - - -

Cash and Cash Equivalents

193 M 81.6 M 122 M 101 M 136 M - - - - - - - -

Book Value

236 M 105 M 118 M 110 M 138 M -10.7 M -249 K - - - - - -

Total Shareholders Equity

236 M 105 M 118 M 110 M 138 M -10.7 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Cabaletta Bio

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

7.29 M - 765 K 1.46 M 1.75 M 2.01 M 2.49 M 2.96 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

30.2 M 17.9 M 18.7 M 17.5 M 12.4 M 10.5 M 11.8 M 12.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-317 M -286 M -258 M -233 M -212 M -196 M -181 M -166 M -150 M -138 M -126 M -113 M -98.7 M -87.1 M -76 M -66.3 M -66.3 M -66.3 M -66.3 M -33 M -33 M -33 M -33 M -12.5 M -12.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

204 M 217 M 240 M 254 M 173 M 185 M 103 M 117 M 91.7 M 102 M 114 M 126 M 123 M 107 M 107 M 115 M 115 M 115 M 115 M 141 M 141 M 141 M 141 M 34.2 M 34.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

171 M 179 M 175 M 193 M 116 M 128 M 93.8 M 81.6 M 61.2 M 47.2 M 59.6 M 122 M 118 M 99.5 M 97.3 M 101 M 101 M 101 M 101 M 136 M 136 M 136 M 136 M 33 M 33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

174 M 200 M 222 M 236 M 161 M 174 M 91.7 M 105 M 91.7 M 102 M 114 M 126 M 123 M 107 M 107 M 115 M 115 M 115 M 115 M 141 M 141 M 141 M 141 M 34.2 M 34.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

174 M 200 M 222 M 236 M 161 M 174 M 91.7 M 105 M 85.9 M 95.5 M 107 M 118 M 117 M 101 M 103 M 110 M 110 M 110 M 110 M 138 M 138 M 138 M 138 M -10.7 M -10.7 M -1.14 M - -249 K - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency